Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Walsh

Showing results (1431-1440 of 1,853) with videos related to

Pageof 186
Sort By:
Diagnostics (Basel, Switzerland)|January 10, 2026
First Clinical Description of Coagulation of Whole Blood with Resonant Acoustic RheometryConnor M Bunch, Weiping Li, Kiera Downey, et al.
Antibiotics (Basel, Switzerland)|January 28, 2026
In Vitro and In Vivo Evaluation of Nitroxoline as an Effective Antimicrobial Alternative to Poultry ProductionYuqing Zhou, Maria M Trush, Lewis Ibbotson, et al.
Antimicrobial Agents and Chemotherapy|March 19, 2014
Molecular characterization of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in the countries of the Gulf cooperation council: dominance of OXA-48 and NDM producersHosam M Zowawi, Anna L Sartor, Hanan H Balkhy, et al.
The Lancet. Infectious Diseases|February 1, 2017
Prevalence, risk factors, outcomes, and molecular epidemiology of mcr-1-positive Enterobacteriaceae in patients and healthy adults from China: an epidemiological and clinical studyYang Wang, Guo-Bao Tian, Rong Zhang, et al.
Mbio|December 29, 2025
Epoxytiglianes potentiate the activity of colistin against resistant <i>Escherichia coli</i> via modification of the bacterial cell membraneManon F Pritchard, Wenya Xue, Jingxiang Wu, et al.
The Lancet. Infectious Diseases|July 10, 2025
Efficacy, immunogenicity, and safety of a next-generation mRNA-1283 COVID-19 vaccine compared with the mRNA-1273 vaccine (NextCOVE): results from a phase 3, randomised, observer-blind, active-controlled trialSpyros Chalkias, Patrick Dennis, Dena Petersen, et al.
Nature Communications|August 1, 2025
Acquisition of Escherichia coli carrying extended-spectrum ß-lactamase and carbapenemase genes by hospitalised children with severe acute malnutrition in NigerKirsty Sands, Aditya Kumar Lankapalli, Giulia Lai, et al.
Vaccine|June 11, 2024
Heterologous SARS-CoV-2 booster vaccine for individuals with hematological malignancies after a primary SARS-CoV-2 mRNA vaccine seriesAmy C Sherman, Simon D van Haren, Ella Borberg, et al.
Journal of Medicinal Chemistry|May 14, 2026
Development of Water-Trapping Pyrrole-2-carboxylic Acids as Broad-Spectrum Metallo-β-lactamase InhibitorsMonisha Singha, Liam A Wilson, Elisabete C C M Moura, et al.
Journal of Medical Microbiology|April 18, 2018
Identification of carbapenem-resistant Pseudomonas aeruginosa in selected hospitals of the Gulf Cooperation Council States: dominance of high-risk clones in the regionHosam M Zowawi, Melanie W Syrmis, Timothy J Kidd, et al.
Pageof 186

Showing results (1431-1440 of 1,853) with videos related to

Sort By:
Pageof 186
Diagnostics (Basel, Switzerland)|January 10, 2026
First Clinical Description of Coagulation of Whole Blood with Resonant Acoustic RheometryConnor M Bunch, Weiping Li, Kiera Downey, et al.
Antibiotics (Basel, Switzerland)|January 28, 2026
In Vitro and In Vivo Evaluation of Nitroxoline as an Effective Antimicrobial Alternative to Poultry ProductionYuqing Zhou, Maria M Trush, Lewis Ibbotson, et al.
Antimicrobial Agents and Chemotherapy|March 19, 2014
Molecular characterization of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in the countries of the Gulf cooperation council: dominance of OXA-48 and NDM producersHosam M Zowawi, Anna L Sartor, Hanan H Balkhy, et al.
The Lancet. Infectious Diseases|February 1, 2017
Prevalence, risk factors, outcomes, and molecular epidemiology of mcr-1-positive Enterobacteriaceae in patients and healthy adults from China: an epidemiological and clinical studyYang Wang, Guo-Bao Tian, Rong Zhang, et al.
Mbio|December 29, 2025
Epoxytiglianes potentiate the activity of colistin against resistant <i>Escherichia coli</i> via modification of the bacterial cell membraneManon F Pritchard, Wenya Xue, Jingxiang Wu, et al.
The Lancet. Infectious Diseases|July 10, 2025
Efficacy, immunogenicity, and safety of a next-generation mRNA-1283 COVID-19 vaccine compared with the mRNA-1273 vaccine (NextCOVE): results from a phase 3, randomised, observer-blind, active-controlled trialSpyros Chalkias, Patrick Dennis, Dena Petersen, et al.
Nature Communications|August 1, 2025
Acquisition of Escherichia coli carrying extended-spectrum ß-lactamase and carbapenemase genes by hospitalised children with severe acute malnutrition in NigerKirsty Sands, Aditya Kumar Lankapalli, Giulia Lai, et al.
Vaccine|June 11, 2024
Heterologous SARS-CoV-2 booster vaccine for individuals with hematological malignancies after a primary SARS-CoV-2 mRNA vaccine seriesAmy C Sherman, Simon D van Haren, Ella Borberg, et al.
Journal of Medicinal Chemistry|May 14, 2026
Development of Water-Trapping Pyrrole-2-carboxylic Acids as Broad-Spectrum Metallo-β-lactamase InhibitorsMonisha Singha, Liam A Wilson, Elisabete C C M Moura, et al.
Journal of Medical Microbiology|April 18, 2018
Identification of carbapenem-resistant Pseudomonas aeruginosa in selected hospitals of the Gulf Cooperation Council States: dominance of high-risk clones in the regionHosam M Zowawi, Melanie W Syrmis, Timothy J Kidd, et al.
Pageof 186